Our Scientific Seminars in Vilnius once again delivered an inspiring experience, featuring a dynamic Joint Session on Hemostasis and Autoimmunity.
The 2025 EEMEA Partnership Meeting brought together colleagues from across the region for a dynamic exchange of ideas, strategies, and inspiration.
Werfen has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) Reagents.
11th International Autoimmunity Seminar: Advancing Insights and Collaboration in Autoimmune Research

The 11th International Autoimmunity Seminar, held on November 5-6, 2024, in Riyadh, Saudi Arabia, brought together over 70 delegates from across the EEMEA region.
The seminar served as a platform to share the latest advancements and foster collaboration in the field of autoimmunity.
The EULAR 2024 Congress in Vienna was held on June 12th-15th and brought together over 12,000 delegates,

